Lineage Cell Therapeutics, Inc. revenue for the last year amounted to 8.95 M USD, the most of which — 8.95 M USD — came from its highest performing source at the moment, Therapeutic Products, the year earlier bringing 14.70 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Lineage Cell Therapeutics, Inc. 8.95 M USD, and the year before that — 14.70 M USD.